After Publication of Data on siRNA Delivery, Leonardo Biosystems Sets Sights on Partnerships

While the company may at some point down the road dip its toes into the drug-development waters, "initially, I don't see us having any in-house discovery efforts," Leonardo CEO Bruce Given said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories